Shanghai Haoyuan Chemexpress Co., Ltd.

Informe acción SHSE:688131

Capitalización de mercado: CN¥7.7b

Shanghai Haoyuan Chemexpress Resultados de beneficios anteriores

Pasado controles de criterios 1/6

Shanghai Haoyuan Chemexpress's earnings have been declining at an average annual rate of -1.2%, while the Life Sciences industry saw earnings growing at 17.2% annually. Revenues have been growing at an average rate of 29.9% per year. Shanghai Haoyuan Chemexpress's return on equity is 5.5%, and it has net margins of 7.2%.

Información clave

-1.2%

Tasa de crecimiento de los beneficios

-8.9%

Tasa de crecimiento del BPA

Crecimiento de la industria Life Sciences 26.8%
Tasa de crecimiento de los ingresos29.9%
Rentabilidad financiera5.5%
Margen neto7.2%
Última actualización de beneficios30 Sep 2024

Actualizaciones de resultados anteriores recientes

Earnings Troubles May Signal Larger Issues for Shanghai Haoyuan Chemexpress (SHSE:688131) Shareholders

May 06
Earnings Troubles May Signal Larger Issues for Shanghai Haoyuan Chemexpress (SHSE:688131) Shareholders

Recent updates

Does Shanghai Haoyuan Chemexpress (SHSE:688131) Have A Healthy Balance Sheet?

Oct 16
Does Shanghai Haoyuan Chemexpress (SHSE:688131) Have A Healthy Balance Sheet?

Shanghai Haoyuan Chemexpress Co., Ltd.'s (SHSE:688131) 25% Jump Shows Its Popularity With Investors

Sep 19
Shanghai Haoyuan Chemexpress Co., Ltd.'s (SHSE:688131) 25% Jump Shows Its Popularity With Investors

Investors Appear Satisfied With Shanghai Haoyuan Chemexpress Co., Ltd.'s (SHSE:688131) Prospects

Jul 13
Investors Appear Satisfied With Shanghai Haoyuan Chemexpress Co., Ltd.'s (SHSE:688131) Prospects

Shanghai Haoyuan Chemexpress (SHSE:688131) Has A Somewhat Strained Balance Sheet

Jun 13
Shanghai Haoyuan Chemexpress (SHSE:688131) Has A Somewhat Strained Balance Sheet

Earnings Troubles May Signal Larger Issues for Shanghai Haoyuan Chemexpress (SHSE:688131) Shareholders

May 06
Earnings Troubles May Signal Larger Issues for Shanghai Haoyuan Chemexpress (SHSE:688131) Shareholders

After Leaping 27% Shanghai Haoyuan Chemexpress Co., Ltd. (SHSE:688131) Shares Are Not Flying Under The Radar

Mar 20
After Leaping 27% Shanghai Haoyuan Chemexpress Co., Ltd. (SHSE:688131) Shares Are Not Flying Under The Radar

Desglose de ingresos y gastos

Cómo gana y gasta dinero Shanghai Haoyuan Chemexpress. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).


Historial de beneficios e ingresos

SHSE:688131 Ingresos, gastos y beneficios (CNY Millions)
FechaIngresosBeneficiosGastos G+AGastos de I+D
30 Sep 242,123153426225
30 Jun 242,055103424228
31 Mar 241,96798404227
31 Dec 231,880127389224
30 Sep 231,764154384232
30 Jun 231,618172350227
31 Mar 231,476178319219
31 Dec 221,358194290202
30 Sep 221,243205259176
30 Jun 221,135212235143
31 Mar 221,044199217119
31 Dec 21969191188103
30 Sep 2191820215187
30 Jun 2184117814179
31 Mar 2173616012169
31 Dec 2063512811765
31 Dec 19409739053
31 Dec 18300188835
30 Jun 1715031460
31 Mar 1713424410
31 Dec 1611718370
30 Sep 1611618330
30 Jun 169611240
31 Mar 169410220
31 Dec 15929200
31 Dec 14673150
31 Dec 13592120

Ingresos de calidad: 688131 has high quality earnings.

Margen de beneficios creciente: 688131's current net profit margins (7.2%) are lower than last year (8.7%).


Análisis del flujo de caja libre vs. Beneficios


Análisis del crecimiento de los beneficios en el pasado

Tendencia de beneficios: 688131's earnings have declined by 1.2% per year over the past 5 years.

Acelerando crecimiento: 688131's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Beneficios vs. Industria: 688131 had negative earnings growth (-0.9%) over the past year, making it difficult to compare to the Life Sciences industry average (-14.4%).


Rentabilidad financiera

Alta ROE: 688131's Return on Equity (5.5%) is considered low.


Rentabilidad económica


Rendimiento del capital invertido


Descubre empresas con buenos resultados en el pasado